| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, Long Island Jewish Medical Center-Queens Hospital Center, Jamaica, New York 11432
The erythropoietic effect of plasma from anemic and nonanemic patients with various cancers was determined by increase in percentage of incorporation of injected 59Fe into circulating RBC's of protein-deprived CF1 adult female mice in 48 hr. In 14 anemic patients with lymphoma or leukemia and in 12 anemic patients with solid tumors, the erythropoietic effect of plasma was significantly reduced compared to 12 normal plasmas but was increased compared to 0.9% NaCl solution controls (p < 0.001). In contrast, the erythropoietic effect of plasma in 8 nonanemic patients (4 lymphomas or leukemias and 4 solid tumors) was similar to normal controls but was significantly different from results in their anemic counterparts (p < 0.001).
1 This work has been supported by Mildred Werner, League of Great Neck for Cancer Research, Greak Neck, New York.
2 Physician-in-Charge of Oncology, to whom reprint requests should be sent at: Department of Medicine, Queens Hospital Center, 82-68 164th Street, Jamaica, N. Y. 11432.
Received 1/28/71. Accepted 5/17/71.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |